Ovctek China Stock Hits Day Low of CNY 14.76 Amid Price Pressure

Ovctek China, Inc., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 5.86% as of March 20, 2026. The stock reached an intraday low of CNY 14.76, reflecting ongoing challenges for the company. Over the past year, Ovctek has reported a notable decrease of 13.63%, contrasting sharply with the China Shanghai Composite, which has gained 16.08% during the same period. The company's performance metrics indicate a consistent underperformance, with a staggering 53.41% decline over the last three years and a 75.39% drop over the past five years. Financial indicators reveal that Ovctek's operating cash flow has reached a low of CNY 795.84 million, while its return on capital employed (ROCE) stands at 10.24%. The company has also reported negative results for the last four consecutive quarters, further highlighting its struggles in the current market environment. Despite a dividend yield of 2.44%, the overall financial landscape suggests a challenging road ahead for Ovctek China, Inc.